HK1249856A1 - 鼻粘膜給藥用藥物組合物 - Google Patents

鼻粘膜給藥用藥物組合物

Info

Publication number
HK1249856A1
HK1249856A1 HK18109333.7A HK18109333A HK1249856A1 HK 1249856 A1 HK1249856 A1 HK 1249856A1 HK 18109333 A HK18109333 A HK 18109333A HK 1249856 A1 HK1249856 A1 HK 1249856A1
Authority
HK
Hong Kong
Prior art keywords
administred
pharmaceutical composition
nasal mucosa
composition intended
intended
Prior art date
Application number
HK18109333.7A
Other languages
English (en)
Inventor
Susumu Maruo
Atsuhiro Nagano
Yuko Nonaka
Ryo Furukawa
Original Assignee
Teijin Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd
Publication of HK1249856A1 publication Critical patent/HK1249856A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
HK18109333.7A 2015-10-30 2018-07-19 鼻粘膜給藥用藥物組合物 HK1249856A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015214481 2015-10-30
PCT/JP2016/082897 WO2017073798A1 (ja) 2015-10-30 2016-10-28 鼻粘膜投与用医薬組成物

Publications (1)

Publication Number Publication Date
HK1249856A1 true HK1249856A1 (zh) 2018-11-16

Family

ID=58630599

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18109333.7A HK1249856A1 (zh) 2015-10-30 2018-07-19 鼻粘膜給藥用藥物組合物

Country Status (17)

Country Link
US (1) US10849978B2 (zh)
EP (1) EP3369429B1 (zh)
JP (1) JP6629877B2 (zh)
KR (1) KR20180066071A (zh)
CN (1) CN108135959B (zh)
AU (1) AU2016346823A1 (zh)
BR (1) BR112018005811A2 (zh)
CA (1) CA2995839A1 (zh)
DK (1) DK3369429T3 (zh)
ES (1) ES2774128T3 (zh)
HK (1) HK1249856A1 (zh)
MX (1) MX2018005363A (zh)
PL (1) PL3369429T3 (zh)
PT (1) PT3369429T (zh)
RU (1) RU2725664C2 (zh)
TW (1) TWI745313B (zh)
WO (1) WO2017073798A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019131723A1 (ja) 2017-12-27 2019-07-04 武田薬品工業株式会社 薬物の投与方法
TW202031283A (zh) * 2018-09-20 2020-09-01 馬克 Ｃ 曼寧 穩定卡貝縮宮素鼻內製劑
FR3088193B1 (fr) 2018-11-13 2021-01-22 Andrea Fox Composition aqueuse, son procede de fabrication, et dispositif d’administration nasal

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5142420A (en) 1974-10-08 1976-04-10 Matsushita Electric Ind Co Ltd Tajushingobunrihoshiki
JPS60123426A (ja) 1983-12-07 1985-07-02 Eisai Co Ltd 経鼻投与用セクレチン製剤
JP2734554B2 (ja) 1988-09-12 1998-03-30 藤沢薬品工業株式会社 インスリン様成長因子ｉの点鼻用液剤
US5158761A (en) * 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
JP3705620B2 (ja) 1994-12-28 2005-10-12 帝国臓器製薬株式会社 経粘膜投与用製剤
US5521283A (en) * 1995-01-31 1996-05-28 Eli Lilly And Company Anti-obesity proteins
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US8268791B2 (en) 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US9023793B2 (en) * 2006-09-29 2015-05-05 Retrophin, Inc. Intranasal carbetocin formulations and methods for the treatment of autism
US20100311655A1 (en) 2007-06-07 2010-12-09 Mdrna, Inc. Intranasal carbetocin formulations and methods for the treatment of autism
US9540420B2 (en) * 2010-03-02 2017-01-10 Tokushima University Mucosal vaccines
SE536091C2 (sv) 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
JP6304744B2 (ja) 2013-12-20 2018-04-04 国立大学法人福井大学 愛着障害治療剤

Also Published As

Publication number Publication date
US20180228902A1 (en) 2018-08-16
MX2018005363A (es) 2018-09-05
CN108135959B (zh) 2021-12-31
KR20180066071A (ko) 2018-06-18
BR112018005811A2 (pt) 2018-10-16
WO2017073798A1 (ja) 2017-05-04
TW201729830A (zh) 2017-09-01
EP3369429A1 (en) 2018-09-05
EP3369429B1 (en) 2019-12-11
RU2018118986A (ru) 2019-12-02
CA2995839A1 (en) 2017-05-04
RU2725664C2 (ru) 2020-07-03
TWI745313B (zh) 2021-11-11
ES2774128T3 (es) 2020-07-16
EP3369429A4 (en) 2018-10-31
JPWO2017073798A1 (ja) 2018-05-31
US10849978B2 (en) 2020-12-01
AU2016346823A1 (en) 2018-03-08
JP6629877B2 (ja) 2020-01-15
CN108135959A (zh) 2018-06-08
PT3369429T (pt) 2020-02-20
DK3369429T3 (da) 2020-02-10
RU2018118986A3 (zh) 2020-01-15
PL3369429T3 (pl) 2020-06-15

Similar Documents

Publication Publication Date Title
SI3030262T1 (sl) Kombiniran farmacevtski sestavek
IL246377A0 (en) Pharmaceutical preparations for oral administration
SG10201802104QA (en) Pharmaceutical composition of s-ketamine hydrochloride
SG10201802106TA (en) Pharmaceutical composition of s-ketamine hydrochloride
HK1244691A1 (zh) 用於施用於粘膜的藥物劑型
ZA201601656B (en) Inhalable pharmaceutical composition
HK1231390A1 (zh) 用於局部給藥的藥用組合物
SI2777689T1 (sl) Nov farmacevtski sestavek za zdravljenje glivičnih infekcij
SG11201601477VA (en) Pharmaceutical composition
HK1249856A1 (zh) 鼻粘膜給藥用藥物組合物
GB201320932D0 (en) Topical pharmaceutical composition
RS59496B1 (sr) Farmaceutska kompozicija za upotrebu u povećanju trofizma sluznice nosa
HK1220143A1 (zh) 藥物組合物
ZA201604100B (en) Gastro-retentive oral pharmaceutical compositions